Is early sestamibi imaging in head and neck cancer affected by MDR status, p53 expression, or cell proliferation?

Nuclear Medicine and Biology

Volumn 25, Issue 6, 1998, Pages 539-541

  Leitha, Thomas ^a   Glaser, Christoph ^a   Lang, Susanna ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Clinical Institute of Pathology   (Austria)

Author keywords

Head neck cancer; Ki 67; MDR; P53; Sestamibi

Indexed keywords

GLYCOPROTEIN P; KI 67 ANTIGEN; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER INVASION; CELL CYCLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GINGIVA; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUTH CARCINOMA; MULTIDRUG RESISTANCE; SALIVARY GLAND; SCINTILLATION CAMERA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; TUMOR VASCULARIZATION;

EID: 0031821594     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(98)00026-2     Document Type: Article

References (15)

1. Banks L., Matlashewski G., Crawford L. Isolation of human p53-specific monoclonal antibodies and their use in the studies of human p53 expression. Eur. J. Biochem. 159:1986;529-534.
2. Bender H., Friedrich E., Zamora P.O., Guhlke S., Biersack H.J. Effects of induction of multi-drug resistance on accumulation of Tc-99m sestamibi in vitro. Anticancer Res. 17:1997;1833-1839.
3. Chiu M.L., Kronauge J.F., Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium(I) in cultured mouse fibroblasts. J. Nucl. Med. 31:1990;1646-1653.
4. Dameron K.M., Volpert O.V., Tainsky M.A., Bouck N. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science. 265:1994;1582-1584.
5. Ingle R.R., Setzen G., Koltai P.J., Monte D., Pastore J., Jennings T.A. p53 Protein expression in benign lesions of the upper respiratory tract. Arch. Otolaryngol. Head Neck Surg. 123:1997;297-300.
6. Ishibashi M., Taguchi A., Sugita Y., Morita S., Kawamura S., Umezaki N., et al. Thallium-201 in brain tumors Relationship between tumor cell activity in astrocytic tumor and proliferating cell nuclear antigen . J. Nucl. Med. 36:(12):1995;2201-2206.
7. Key G., Becker M.H., Baron B., Duchrow M., Schlüter C., Flad H.D., et al. New Ki-67 equivalent murine monoclonal antibodies (MIB1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. Lab. Invest. 68:1993;629-636.
8. Kostakoglu L., Elahi N., Kiratli P., Ruacan S., Sayek I., Baltali E., et al. Clinical validation of the influence of P-glycoprotein on technetium-99m sestamibi uptake in malignant tumors. J. Nucl. Med. 38:1997;1003-1008.
9. Koukourakis M.I., Koukouraki S., Giatromanolaki A., Skarlatos J., Georgoulias V., Karkavitsas N. Non-small-cell lung cancer functional imaging Increased hexakis 2 methoxy isobutyl isonitrile tumor clearance correlates with resistance to cytotoxic treatment . Clin. Cancer Res. 3:(5):1997;749-754.
10. Leitha T., Glaser C., Pruckmayer M., Rasse M., Millesi W., Lang S. et al. (in press) Sestamibi in primary and recurrent head-neck tumors and the contribution of image fusion with bone SPECT. J. Nucl. Med.
11. Omar W.S., Eissa S., Moustafa H., Farag H., Ezzar I., Abdeldayem H.M. Role of thallium-201 chloride and Tc-99m methoxy isobutyl isonitrile (sestamibi) in evaluation of breast masses Correlation with the immunohistochemical characteristic parameters (Ki-67, PCNA, BCL 2 and angiogenesis) in malignant lesions . Anticancer Res. 17:1997;1639-1644.
12. Piwnica-Worms D., Rao V.V., Kronauge J.F., Croop J.M. Characterization of multidrug resistance P-glycoprotein transport function with an organotechnetium cation. Biochemistry. 34:1995;12210-12220.
13. Scheper R.J., Bulte J.W.M., Brakkee J.G.P., Quak J.J., van der Schoot E., Balm A.J., et al. Monoclonal antibody JSB-1 detects a highly conserved epitope on the p-glycoprotein associated with multi-drug-resistance. Int. J. Cancer. 42:1988;389-394.
14. Scopinaro F., Schillaci O., Scarpini M., Mingazzini O.L., Di Macio L., Banci M., et al. Technetium-99m sestamibi An indicator of breast cancer invasiveness . Eur. J. Nucl. Med. 21:1994;984-987.
15. Taguchi A. Clinical significance of thallium-201 single-photon emission computerized tomography (Tl-201 SPECT) in the evaluation of viability of gliomas. Kurume Med. J. 39:(4):1992;267-278.